Accumulation of adenosine 3',5'-monophosphate in rat brain slices: effects of prostaglandins.
D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone / Q000494:pharmacology; D000241:Adenosine / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000378:metabolism*; D002395:Catecholamines / Q000494:pharmacology; D002531:Cerebellum / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D006168:Guinea Pigs; D006624:Hippocampus / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008526:Medulla Oblongata / Q000378:metabolism; D008636:Mesencephalon / Q000378:metabolism; D009020:Morphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011149:Pons / Q000378:metabolism; D011448:Prostaglandin Antagonists; D011453:Prostaglandins / Q000494:pharmacology*; D011454:Prostaglandins A / Q000494:pharmacology; D011458:Prostaglandins E / Q000494:pharmacology; D011460:Prostaglandins F / Q000494:pharmacology; D051381:Rats; D013788:Thalamus / Q000378:metabolism; D013997:Time Factors; D014701:Veratridine / Q000494:pharmacology
D002395:Catecholamines; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D011454:Prostaglandins A; D011458:Prostaglandins E; D011460:Prostaglandins F; D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; D009270:Naloxone; D014701:Veratridine; D009020:Morphine; D000242:Cyclic AMP; D000241:Adenosine; D007545:Isoproterenol; D010646:Phentolamine